Navigation Links
Boehringer Ingelheim to present new data at ASCO annual meeting regarding its investigational compound afatinib in EGFR-mutation positive patients with advanced NSCLC
Date:5/25/2011

trial evaluating afatinib in NSCLC patients with EGFR mutations, either treatment naïve or after one line of chemotherapy.

Boehringer Ingelheim recently completed enrollment in the phase III LUX-Lung 3 trial that will specifically investigate afatinib as a first-line treatment in patients with advanced NSCLC with EGFR mutations.  Another ongoing phase III trial, LUX-Lung 6, also investigates the efficacy and safety of afatinib compared to standard chemotherapy for first-line treatment of NSCLC patients with EGFR mutations in different geographical regions.

LUX-Lung 4 is a phase I/II trial of afatinib in NSCLC patients who have progressed after conventional EGFR-TKI treatment.  

LUX-Lung 5 is a global phase III trial in patients previously treated with erlotinib or gefitinib. This is the first randomized phase III trial investigating whether patients who initially benefit from treatment with afatinib alone may further benefit from afatinib beyond progression when given in combination with chemotherapy.

About Lung Cancer

Lung cancer is the second most common cancer and kills more people than any other cancer. In 2010, approximately 222,520 new cases of lung cancer were diagnosed in the United States, with 157,300 Americans dying from the disease.  NSCLC is the most common form of lung cancer, accounting for about 85 percent of all lung cancers.(7) Lung cancer remains an area of high unmet need, especially in its advanced stages where it is particularly aggressive and patients have limited treatment options.

About QIAGEN

QIAGEN is the leading global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are used to make such isolated bio-molecules visible. QIAGEN has developed and markets more than 500 sample and assay products as well as automated solutions
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
2. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
3. Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
4. Boehringer Ingelheim Unveils Diabetes Pipeline
5. Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer
6. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
7. New Boehringer Ingelheim Science Quest Mobile Laboratory Brings Hands-On Science Education to Priority Connecticut Elementary Schools
8. Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
9. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
10. Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes
11. Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 20, 2013  Upsher-Smith Laboratories, Inc., a specialty ... treatments for diseases of the central nervous system, ... website, upsher-smith.com . The new site celebrates ... of the company,s mission statement – Advancing Pharmacotherapy, ... around people with a story to tell, a ...
(Date:5/20/2013)... , May 20, 2013 /PRNewswire-iReach/ -- Specific Technologies, ... first study demonstrating detection of pathogenic bacteria, including ... and Bacillus anthracis which feature ... list of potential bio-threats. This seminal study, conducted ... Laboratory, Salisbury (DSTL), ...
(Date:5/20/2013)... -- TRACE International today released its Global Enforcement Report ... individuals and government or business entities for bribery and ... 2012 is the third in an annual series from ... "Although the number of outbound enforcement actions fell last ... said Alexandra Wrage , TRACE Founder ...
Breaking Medicine Technology:Upsher-Smith Introduces Newly Redesigned Corporate Website 2Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria 2TRACE Releases 2012 Global Enforcement Report 2TRACE Releases 2012 Global Enforcement Report 3
... Feb. 23, 2012 Escalon Medical Corp.,s (Nasdaq Market: ... it has successfully completed the outsourced manufacturing of its ... instruments for sale. Drew has also identified an outsourcing ... units being available for sale by the summer of ...
... 23, 2012 The management of ReBuilder Medical Technologies, ... has filed complaints with the U.S. Securities Exchange Commission ... certain traders of the Company shares may have engaged ... the Company,s shares.   The firmed has hired a forensic ...
Cached Medicine Technology:Escalon Announces That the Restructuring of Its IVD Business is Largely Completed 2Escalon Announces That the Restructuring of Its IVD Business is Largely Completed 3Escalon Announces That the Restructuring of Its IVD Business is Largely Completed 4ReBuilder (RBRM) Files Complaints Against Stock Traders 2
(Date:5/21/2013)... Southborough, MA (PRWEB) May 21, 2013 ... a global leader in the development and standardization ... method, jointly developed by Brunswick Laboratories and the ... measuring antioxidants in foods. This decision comes after ... (ERP) chaired by James Harnly of the U.S. ...
(Date:5/21/2013)... Kansas City, MO (PRWEB) May 21, 2013 ... announcing updated news for women who have used the ... patients filing lawsuits alleging blood clot injuries has increased ... those using popular prescription drugs and devices with the ... can find out if others are experiencing similar side ...
(Date:5/21/2013)... Fulton, MD (PRWEB) May 21, 2013 ... don’t often think about. Not only is it more difficult ... down can become tricky. Fortunately, there are a variety of ... extra help. One such product is the raised toilet seat. ... the floor, making it easier to stand back up or ...
(Date:5/20/2013)... CA (PRWEB) May 21, 2013 USA ... A Transcendent Approach to Peak Performance" won the top ... Non-Fiction Category. Chosen over a multitude of international ... global attention and critical acclaim from both mainstream and ... levels - mentally, physically and spiritually. , ...
(Date:5/20/2013)... 2013 Heritage Woods of Gurnee ... County, Illinois, is hosting Breakfast and Bingo at 8:30 ... is located at 3775 Grand Ave. in Gurnee, Illinois, ... Medicaid, who need some help to maintain their independence. ... games of bingo," says Tammy Temaner-Rosas, Director of Marketing ...
Breaking Medicine News(10 mins):Health News:AOAC International Approves ORAC as First Action Official Method 2Health News:DrugRisk Update Shows Increase in NuvaRing Blood Clot Lawsuits 2Health News:JustHomeMedical.com Launches Raised Toilet Seats Category 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 3Health News:Heritage Woods of Gurnee Affordable Assisted Living Community to Host Breakfast and Bingo 2
... The US-China Business,Council (USCBC) today encouraged American ... in China in response to the devastating earthquake,that ... member companies have already pledged several million dollars ... to earthquake victims and many,have established matching funds ...
... release earlier this,year, the FDA issued a Public Health ... and cold products should not,be used to treat infants ... and potentially life-threatening side effects can occur from such,use., ... that OTC cough,and cold medicines not be used for ...
... cholesterol-lowering drugs showed some benefits in preliminary trial ... appear to be associated with a lower risk ... fibrillation in postmenopausal women with coronary disease. , ... atrial fibrillation, but it certainly supports the hypothesis ...
... SAN DIEGO, May 15 - RealAge, Inc., ... Life to the Youngest" and,pursue health and wellness ... Award at the 2008 Pharmaceutical Advertising and Marketing,Excellence ... The,RealAge/ARD Marketing Valtrex(R) campaign was honored in the ...
... HIV/AIDS Fundraising Spectacular Takes Place June 14 & 15 at Paris Las ... ... May 15 It,s an all-original, all-singing,all-dancing musical journey across America when ... production show. The spectacular is staged June 14 and 15 in Le,Theatre ...
... May 15 /PRNewswire-FirstCall/ - SXC Health Solutions, Corp.,("SXC" or ... leading provider of,pharmacy benefits management services, announces that Mark ... CFO, will present at the,FBR Capital Markets 12th Annual ... SXC,s presentation will take place on Thursday, May 29,2008 ...
Cached Medicine News:Health News:US Companies Aid Chinese Earthquake Victims 2Health News:US Companies Aid Chinese Earthquake Victims 3Health News:US Companies Aid Chinese Earthquake Victims 4Health News:US Companies Aid Chinese Earthquake Victims 5Health News:US Companies Aid Chinese Earthquake Victims 6Health News:US Companies Aid Chinese Earthquake Victims 7Health News:Saline is Safe Alternative to Harmful Cough and Cold Products 2Health News:Statins May Help Older Women Control Irregular Heartbeat 2Health News:RealAge Wins Silver PhAME Award 2Health News:Golden Rainbow Takes a Musical Journey for Its 22nd Annual 'Ribbon of Life' Production Show 2
Used to introduce balloon, electrode, closed or non-tapered end catheters and other devices for intervention....
Used to introduce balloon, diagnostic and guiding catheters, or other devices for intervention....
Used to introduce large balloon, closed and non-tapered end catheters or other devices for intervention....
Used for the introduction of catheters, balloons and other vascular devices....
Medicine Products: